Head-to-head · Cost-Efficiency Index
Found vs ClickSlim
Two GLP-1 programs on the bench, scored on the same six factors. Here's how their real cost of ownership compares — and which one we'd start with.
Found
Cost-first shoppers who also want behavior-change coaching bundled with the medication.
Visit FoundClickSlim
Shoppers comparing tirzepatide bundles who want the post-introductory price stated up front.
Visit ClickSlimThe verdict
Found takes it, leading the Cost-Efficiency Index 88 to 48. The cheapest identical price on both molecules nationwide — unbeatable raw cost-per-month, capped only by a coaching subscription you can't fully unbundle. ClickSlim still earns a C — Shoppers comparing tirzepatide bundles who want the post-introductory price stated up front.
Worth knowing either way: our overall #1 pick is CoreAge Rx (Cost-Efficiency Index 94/100 — the top of the board). See how it stacks up: CoreAge Rx vs Found.
Factor by factor
Both providers scored on our six Cost-Efficiency Index factors. The stronger side on each row is marked in teal.
Normalized Cost/Month
Price Transparency
Nationwide Access
Formulation Options
Clinical Oversight
Contract Flexibility
Pricing, coverage & formulary
The disclosed facts behind the scores. Lower price wins its row (teal).
| Spec | Found | ClickSlim |
|---|---|---|
| Cost-Efficiency Index | 88/100 | 48/100 |
| Semaglutide / mo | $129/mo | Not disclosed |
| Tirzepatide / mo | $129/mo | $349/mo (compounded) |
| Semaglutide / yr (modeled) | $1,548 | — |
| Tirzepatide / yr (modeled) | $1,548 | $4,188 |
| Coverage | All 50 states | Coverage not published |
| Oral / sublingual | No | No |
| Brand-name access | Compounded only | Compounded only |
| Rank on the board | #7 | #395 |
Found
88/100Where the value is
- Lowest cost-per-month on the board — identical $129 on both molecules
- Nationwide
- Strong behavior-change program adds value
The tradeoffs
- Coaching subscription can't be unbundled, which reduces contract flexibility
- Compounded only
ClickSlim
48/100Where the value is
- Both the introductory and the ongoing price are published, so the step-up is visible before you buy
- States plainly that it is not a pharmacy or a drug manufacturer and that medication is dispensed by a licensed third party
- Text support line published with stated hours
The tradeoffs
- Its own NAD+ product card is labelled CONTAINS TIRZEPATIDE, which contradicts the product it is selling
- No state list is published; the site says only that services are available in most States
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Cost-Efficiency Index. Pricing, states and verification reflect each provider's public disclosures at last review; prices change — confirm on the provider's site. Not medical advice. See our disclosure.